|
Back to Home » February 2017 News » A2 Acquisition Corp. Announces TSXV Conditional Approval and the Increase of Medicenna Therapeutics Inc. Offering Size to $4,000,000 |
A2 Acquisition Corp. Announces TSXV Conditional Approval and the Increase of Medicenna Therapeutics Inc. Offering Size to $4,000,000 |
February 28, 2017
CALGARY, ALBERTA--(Marketwired - Feb. 27, 2017) -
Source URL: http://www.marketwired.com/mw/release.do?id=2198953&sourceType=3
|
|
|
|
